Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Not applicableStudy completedNCT01213004
What this trial is testing

Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers

Who this might be right for
Gastric CancerLung Cancer
Memorial Sloan Kettering Cancer Center 52
Early research (Phase 1)Not Yet RecruitingNCT07806500
What this trial is testing

Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors

Who this might be right for
Squamous Cell Lung CancerGastric CancerEsophageal Cancer
Beijing Anjianxi Bio-Medical Technology Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT01158287
What this trial is testing

Sorafenib. ICORG 06-41, V4

Who this might be right for
Esophageal CancerGastric Cancer
Cancer Trials Ireland 54
Testing effectiveness (Phase 2)Study completedNCT01364493
What this trial is testing

Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT07142421
What this trial is testing

Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
First Affiliated Hospital of Zhejiang University 35
Testing effectiveness (Phase 2)Study completedNCT02591784
What this trial is testing

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Who this might be right for
Esophageal
Biotech Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)UnknownNCT03959293
What this trial is testing

Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastric Cancer
Federation Francophone de Cancerologie Digestive 107
Not applicableUnknownNCT05431738
What this trial is testing

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

Who this might be right for
Stent MigrationGastroEsophageal Cancer
Société Française d'Endoscopie Digestive 180
Not applicableStudy completedNCT03081715
What this trial is testing

PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Hangzhou Cancer Hospital 16
Not applicableLooking for participantsNCT02988921
What this trial is testing

MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy

Who this might be right for
Esophagus CancerEsophagogastric Junction Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Testing effectiveness (Phase 2)UnknownNCT03387904
What this trial is testing

Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 120
Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Not applicableLooking for participantsNCT03734952
What this trial is testing

Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy

Who this might be right for
Radiation Oncology
Fujian Medical University Union Hospital 537
Testing effectiveness (Phase 2)Looking for participantsNCT06067438
What this trial is testing

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Who this might be right for
Atrial FibrillationEsophageal Carcinoma
OHSU Knight Cancer Institute 90
Large-scale testing (Phase 3)UnknownNCT05817201
What this trial is testing

Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy

Who this might be right for
Esophageal CancerRadiation TherapyImmunotherapy+1 more
Taizhou Hospital 60
Testing effectiveness (Phase 2)UnknownNCT02937519
What this trial is testing

Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer

Who this might be right for
Esophageal Neoplasms
Guiyang Medical University 160
Not applicableLooking for participantsNCT04674267
What this trial is testing

Resilience and Equity in Aging, Cancer, and Health (REACH)

Who this might be right for
Gastric CancerColon CancerEsophageal Cancer+3 more
Dana-Farber Cancer Institute 147
Not applicableStudy completedNCT03314311
What this trial is testing

Rehabilitative Strategies Following Oesophageal Cancer

Who this might be right for
Esophageal Cancer
University of Dublin, Trinity College 44
Not applicableLooking for participantsNCT06192771
What this trial is testing

Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically

Who this might be right for
DysphagiaHead and Neck Cancer
University Health Network, Toronto 40
Next Page